Yigal Nochomovitz
Stock Analyst at Citigroup
(2.29)
# 2,402
Out of 4,829 analysts
296
Total ratings
37.18%
Success rate
-1.91%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Yigal Nochomovitz
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ARVN Arvinas | Maintains: Neutral | $10 → $9.5 | $6.61 | +43.72% | 10 | May 5, 2025 | |
| ARDX Ardelyx | Maintains: Buy | $11 → $10 | $3.62 | +176.24% | 15 | May 2, 2025 | |
| SMMT Summit Therapeutics | Upgrades: Buy | $23 → $35 | $23.96 | +46.08% | 5 | Mar 26, 2025 | |
| LENZ LENZ Therapeutics | Maintains: Buy | $44 → $47 | $26.34 | +78.44% | 2 | Mar 20, 2025 | |
| ZYME Zymeworks | Maintains: Buy | $18 → $19 | $11.31 | +68.07% | 16 | Mar 7, 2025 | |
| RIGL Rigel Pharmaceuticals | Maintains: Buy | $49 → $55 | $18.75 | +193.33% | 11 | Mar 6, 2025 | |
| SNDX Syndax Pharmaceuticals | Maintains: Buy | $45 → $42 | $10.70 | +292.52% | 8 | Mar 4, 2025 | |
| KRYS Krystal Biotech | Maintains: Neutral | $206 → $215 | $132.18 | +62.66% | 4 | Feb 20, 2025 | |
| CADL Candel Therapeutics | Initiates: Buy | $25 | $4.81 | +419.75% | 1 | Feb 20, 2025 | |
| CRSP CRISPR Therapeutics AG | Maintains: Buy | $89 → $82 | $35.62 | +130.21% | 21 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $33 | $5.81 | +467.99% | 1 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $89 → $97 | $40.90 | +137.16% | 16 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $8 | $0.40 | +1,901.50% | 10 | Nov 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $6 | $0.77 | +674.89% | 5 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $63 → $51 | $17.30 | +194.80% | 14 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $27 | $9.06 | +198.01% | 1 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $8 → $2 | $0.95 | +110.99% | 4 | Oct 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $36 | $20.15 | +78.66% | 2 | Sep 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $58 | $17.42 | +232.95% | 3 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $22 | $1.63 | +1,249.69% | 8 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $14 | $1.43 | +879.02% | 14 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.5 → $1.2 | $0.29 | +313.65% | 9 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $38 | $8.28 | +358.94% | 7 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $14 | $5.08 | +175.59% | 6 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.8 → $2 | $1.61 | +24.61% | 3 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $123 → $66 | $29.24 | +125.72% | 8 | Feb 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $48 | $10.98 | +337.16% | 5 | Feb 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $4.60 | +334.78% | 1 | Jan 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $8 | $2.19 | +265.30% | 10 | Oct 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.5 → $1 | $6.90 | -85.51% | 4 | Sep 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $50 → $35 | $7.31 | +378.80% | 12 | Aug 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $130 → $133 | $35.11 | +278.81% | 15 | Jun 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $8 | $0.70 | +1,041.23% | 11 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $6 | $0.91 | +556.38% | 7 | May 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $16 | $1.58 | +912.66% | 3 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $10 | $1.04 | +861.54% | 6 | Mar 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $0.72 | +2,132.45% | 1 | Oct 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $44 | $3.41 | +1,190.32% | 2 | Sep 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $12 | $2.44 | +392.09% | 1 | Sep 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $2.91 | - | 14 | Sep 28, 2021 |
Arvinas
May 5, 2025
Maintains: Neutral
Price Target: $10 → $9.5
Current: $6.61
Upside: +43.72%
Ardelyx
May 2, 2025
Maintains: Buy
Price Target: $11 → $10
Current: $3.62
Upside: +176.24%
Summit Therapeutics
Mar 26, 2025
Upgrades: Buy
Price Target: $23 → $35
Current: $23.96
Upside: +46.08%
LENZ Therapeutics
Mar 20, 2025
Maintains: Buy
Price Target: $44 → $47
Current: $26.34
Upside: +78.44%
Zymeworks
Mar 7, 2025
Maintains: Buy
Price Target: $18 → $19
Current: $11.31
Upside: +68.07%
Rigel Pharmaceuticals
Mar 6, 2025
Maintains: Buy
Price Target: $49 → $55
Current: $18.75
Upside: +193.33%
Syndax Pharmaceuticals
Mar 4, 2025
Maintains: Buy
Price Target: $45 → $42
Current: $10.70
Upside: +292.52%
Krystal Biotech
Feb 20, 2025
Maintains: Neutral
Price Target: $206 → $215
Current: $132.18
Upside: +62.66%
Candel Therapeutics
Feb 20, 2025
Initiates: Buy
Price Target: $25
Current: $4.81
Upside: +419.75%
CRISPR Therapeutics AG
Feb 18, 2025
Maintains: Buy
Price Target: $89 → $82
Current: $35.62
Upside: +130.21%
Jan 7, 2025
Initiates: Buy
Price Target: $33
Current: $5.81
Upside: +467.99%
Dec 9, 2024
Maintains: Buy
Price Target: $89 → $97
Current: $40.90
Upside: +137.16%
Nov 29, 2024
Maintains: Buy
Price Target: $13 → $8
Current: $0.40
Upside: +1,901.50%
Nov 26, 2024
Maintains: Buy
Price Target: $30 → $6
Current: $0.77
Upside: +674.89%
Nov 6, 2024
Maintains: Buy
Price Target: $63 → $51
Current: $17.30
Upside: +194.80%
Oct 8, 2024
Initiates: Buy
Price Target: $27
Current: $9.06
Upside: +198.01%
Oct 2, 2024
Downgrades: Neutral
Price Target: $8 → $2
Current: $0.95
Upside: +110.99%
Sep 11, 2024
Maintains: Buy
Price Target: $30 → $36
Current: $20.15
Upside: +78.66%
Aug 27, 2024
Maintains: Buy
Price Target: $60 → $58
Current: $17.42
Upside: +232.95%
Aug 27, 2024
Maintains: Buy
Price Target: $45 → $22
Current: $1.63
Upside: +1,249.69%
Aug 15, 2024
Maintains: Buy
Price Target: $16 → $14
Current: $1.43
Upside: +879.02%
Jun 18, 2024
Maintains: Neutral
Price Target: $3.5 → $1.2
Current: $0.29
Upside: +313.65%
Jun 3, 2024
Maintains: Buy
Price Target: $36 → $38
Current: $8.28
Upside: +358.94%
May 7, 2024
Maintains: Buy
Price Target: $15 → $14
Current: $5.08
Upside: +175.59%
Apr 18, 2024
Maintains: Neutral
Price Target: $1.8 → $2
Current: $1.61
Upside: +24.61%
Feb 29, 2024
Maintains: Buy
Price Target: $123 → $66
Current: $29.24
Upside: +125.72%
Feb 8, 2024
Maintains: Buy
Price Target: $40 → $48
Current: $10.98
Upside: +337.16%
Jan 30, 2024
Initiates: Buy
Price Target: $20
Current: $4.60
Upside: +334.78%
Oct 17, 2023
Maintains: Buy
Price Target: $25 → $8
Current: $2.19
Upside: +265.30%
Sep 18, 2023
Maintains: Neutral
Price Target: $1.5 → $1
Current: $6.90
Upside: -85.51%
Aug 21, 2023
Maintains: Sell
Price Target: $50 → $35
Current: $7.31
Upside: +378.80%
Jun 7, 2023
Maintains: Buy
Price Target: $130 → $133
Current: $35.11
Upside: +278.81%
May 31, 2023
Maintains: Buy
Price Target: $6 → $8
Current: $0.70
Upside: +1,041.23%
May 26, 2023
Maintains: Buy
Price Target: $5 → $6
Current: $0.91
Upside: +556.38%
Apr 5, 2023
Maintains: Buy
Price Target: $24 → $16
Current: $1.58
Upside: +912.66%
Mar 2, 2023
Maintains: Buy
Price Target: $9 → $10
Current: $1.04
Upside: +861.54%
Oct 14, 2022
Initiates: Buy
Price Target: $16
Current: $0.72
Upside: +2,132.45%
Sep 16, 2022
Maintains: Buy
Price Target: $45 → $44
Current: $3.41
Upside: +1,190.32%
Sep 16, 2022
Maintains: Buy
Price Target: $16 → $12
Current: $2.44
Upside: +392.09%
Sep 28, 2021
Upgrades: Buy
Price Target: n/a
Current: $2.91
Upside: -